RNAimmune: RNAimmune accelerates R&D into mRNA vaccine, drug discovery
RNAimmune has set up its China R&D center in Guangzhou Bio-Island
Read full article »
President & CEO
Dong Shen
RNAimmune is a Maryland-based biopharmaceutical company that develops and commercializes therapeutics for the treatment of cancer, infectious and rare diseases.
Read more